NO20010326L - FSH og FSH-variantformuleringer, produkter og fremgangsmÕter - Google Patents

FSH og FSH-variantformuleringer, produkter og fremgangsmÕter

Info

Publication number
NO20010326L
NO20010326L NO20010326A NO20010326A NO20010326L NO 20010326 L NO20010326 L NO 20010326L NO 20010326 A NO20010326 A NO 20010326A NO 20010326 A NO20010326 A NO 20010326A NO 20010326 L NO20010326 L NO 20010326L
Authority
NO
Norway
Prior art keywords
fsh
products
methods
variant formulations
formulations
Prior art date
Application number
NO20010326A
Other languages
English (en)
Other versions
NO20010326D0 (no
Inventor
James Arthur Hoffmann
Jirong Lu
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27536687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20010326(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20010326D0 publication Critical patent/NO20010326D0/no
Publication of NO20010326L publication Critical patent/NO20010326L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Dispersion Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20010326A 1998-07-23 2001-01-19 FSH og FSH-variantformuleringer, produkter og fremgangsmÕter NO20010326L (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US9390698P 1998-07-23 1998-07-23
US9461198P 1998-07-30 1998-07-30
US9476798P 1998-07-31 1998-07-31
US9871198P 1998-09-01 1998-09-01
US10069698P 1998-09-17 1998-09-17
PCT/US1999/016031 WO2000004913A1 (en) 1998-07-23 1999-07-15 Fsh and fsh variant formulations, products and methods

Publications (2)

Publication Number Publication Date
NO20010326D0 NO20010326D0 (no) 2001-01-19
NO20010326L true NO20010326L (no) 2001-03-20

Family

ID=27536687

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010326A NO20010326L (no) 1998-07-23 2001-01-19 FSH og FSH-variantformuleringer, produkter og fremgangsmÕter

Country Status (24)

Country Link
EP (2) EP1188444B1 (no)
JP (1) JP4719357B2 (no)
KR (1) KR20010083126A (no)
CN (1) CN1309567A (no)
AR (1) AR020618A1 (no)
AT (2) ATE228850T1 (no)
AU (1) AU776823B2 (no)
BR (1) BR9912243A (no)
CA (1) CA2335340C (no)
CO (1) CO5090905A1 (no)
DE (2) DE69904262T3 (no)
DK (1) DK0974359T4 (no)
ES (2) ES2250290T3 (no)
HK (1) HK1026615A1 (no)
ID (1) ID28747A (no)
IL (1) IL140984A0 (no)
MY (1) MY135913A (no)
NO (1) NO20010326L (no)
NZ (1) NZ508874A (no)
PE (1) PE20000939A1 (no)
PL (1) PL346127A1 (no)
PT (1) PT974359E (no)
SI (1) SI0974359T1 (no)
WO (1) WO2000004913A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6414123B1 (en) 1997-10-21 2002-07-02 Vitro Diagnostics, Inc. Method for purifying FSH
US20030166525A1 (en) 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
TWI277425B (en) 1999-04-13 2007-04-01 Lilly Co Eli Pulmonary administration of dry powder formulations for treating infertility
TWI318100B (en) 2001-03-01 2009-12-11 Lonza Ag Preservative blends containing quaternary ammonium compounds
CA2518903C (en) * 2003-04-02 2013-02-05 Ares Trading S.A. Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant
US7740884B2 (en) 2003-06-20 2010-06-22 Ares Trading S.A. Freeze-dried FSH/LH formulations
KR101105871B1 (ko) * 2005-09-27 2012-01-16 주식회사 엘지생명과학 인 난포자극호르몬의 안정한 용액 제형
NZ579740A (en) * 2007-02-08 2011-12-22 Aspenbio Pharma Inc Compositions and methods including expression and bioactivity of bovine follicle stimulating hormone
CN101720332B (zh) 2007-06-28 2014-08-13 拉蒂奥法姆有限责任公司 生产促卵泡激素的细胞克隆
SI2219607T1 (sl) * 2007-11-01 2012-09-28 Merck Serono Sa Tekoäśe formulacije lh
CN101970010A (zh) * 2008-02-08 2011-02-09 拜奥吉耐里克斯股份公司 促卵泡激素的液体制剂
CN102309745B (zh) * 2008-09-17 2013-05-08 上海天伟生物制药有限公司 一种卵泡刺激素冻干针剂
EP2445552B1 (de) 2009-06-24 2015-10-14 Tecpharma Licensing AG Verabreichungsgerät mit priming funktion
EP2325194A1 (en) 2009-11-24 2011-05-25 Glycotope GmbH Process for the purification of glycoproteins
WO2011076280A1 (de) 2009-12-23 2011-06-30 Tecpharma Licensing Ag Injektionsvorrichtung mit einer nadelschutzhülse
WO2011076281A1 (de) 2009-12-23 2011-06-30 Tecpharma Licensing Ag Entfernen einer nadelschutzkappe von einer nadel
US8684744B2 (en) 2010-02-11 2014-04-01 Finox Ag Injection training dummy
CN102821782B (zh) * 2010-02-12 2015-07-15 印塔斯生物制药有限公司 促卵泡激素的液体配制品
EP2417982A1 (en) * 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
KR20140018970A (ko) * 2011-04-22 2014-02-13 샹하이 테크웰 바이오파마슈티컬 컴퍼니, 리미티드 저수준 잔류용매를 함유한 당단백질 조성물 및 그 제조방법과 용도
JP5750471B2 (ja) * 2013-05-22 2015-07-22 Ｊｃｒファーマ株式会社 組換え体ヒトｆｓｈの製造方法
CN103539860B (zh) * 2013-11-01 2014-12-03 广州优联康医药科技有限公司 一种长效重组人促卵泡激素融合蛋白
CN103554269B (zh) * 2013-11-01 2015-02-11 广州联康生物科技有限公司 重组猪促卵泡激素融合蛋白
CN103539861B (zh) * 2013-11-01 2015-02-18 广州联康生物科技有限公司 长效重组人促卵泡激素融合蛋白
KR101699677B1 (ko) * 2013-11-12 2017-01-24 카딜라 핼쓰캐어 리미티드 고나도트로핀을 위한 제제
CN113198005A (zh) * 2015-09-17 2021-08-03 葛莱高托普有限公司 具有提高的稳定性的哺乳动物促卵泡激素组合物
GB201603280D0 (en) * 2016-02-24 2016-04-13 Ferring Bv Stable liquid gonadotropin formulation

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB839300A (en) * 1957-09-05 1960-06-29 Organon Labor Ltd Adrenocorticotropic hormone preparations and process for making same
US4659696A (en) † 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
US5162306A (en) * 1987-01-23 1992-11-10 Donaldson Lloyd E Composition and method for producing superovulation in mammals
IT1206302B (it) * 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
FR2623715B1 (fr) * 1987-11-26 1990-12-21 Lafon Labor Structures peptidiques, immunogenes les contenant et leurs applications au controle de la fertilite
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
JP4018133B2 (ja) * 1992-07-31 2007-12-05 ジェネンテック・インコーポレーテッド ヒト成長ホルモン水性製剤
US5661125A (en) * 1992-08-06 1997-08-26 Amgen, Inc. Stable and preserved erythropoietin compositions
DE69508985T2 (de) † 1994-02-21 1999-08-19 Takeda Chemical Industries Ltd Polyester Matrix für eine pharmazeutische Zusammensetzung mit verzögerter Freigabe
JP2758154B2 (ja) † 1995-04-06 1998-05-28 エフ・ホフマン−ラ ロシユ アーゲー インターフェロンを含む液体製剤
IL124004A (en) * 1995-11-07 2003-10-31 Genentech Inc Stable pharmaceutical composition comprising ngf
GB2317010A (en) * 1996-09-04 1998-03-11 Eev Ltd Gas sensor detecting only non-reflected light
TW518235B (en) * 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
US6287587B2 (en) † 1997-07-15 2001-09-11 Takeda Chemical Industries, Ltd. Process for producing sustained-release preparation by in-water drying
MY120063A (en) * 1997-12-09 2005-08-30 Lilly Co Eli Stabilized teriparatide solutions
JP2000151148A (ja) * 1998-11-13 2000-05-30 Mitsumi Electric Co Ltd 携帯用電子機器のコード接続構造

Also Published As

Publication number Publication date
ES2183486T3 (es) 2003-03-16
DK0974359T4 (da) 2009-06-29
SI0974359T1 (en) 2003-04-30
EP0974359A3 (en) 2001-02-07
IL140984A0 (en) 2002-02-10
HK1026615A1 (en) 2000-12-22
KR20010083126A (ko) 2001-08-31
CA2335340C (en) 2013-03-05
AU4998099A (en) 2000-02-14
DE69904262T3 (de) 2009-08-13
JP4719357B2 (ja) 2011-07-06
EP1188444A1 (en) 2002-03-20
JP2002521342A (ja) 2002-07-16
EP0974359B2 (en) 2009-04-22
PT974359E (pt) 2003-02-28
DE69928296D1 (de) 2005-12-15
MY135913A (en) 2008-07-31
CO5090905A1 (es) 2001-10-30
EP1188444B1 (en) 2005-11-09
DE69904262T2 (de) 2003-07-24
CN1309567A (zh) 2001-08-22
PL346127A1 (en) 2002-01-28
ES2250290T3 (es) 2006-04-16
ID28747A (id) 2001-06-28
NO20010326D0 (no) 2001-01-19
PE20000939A1 (es) 2000-09-20
EP0974359B1 (en) 2002-12-04
BR9912243A (pt) 2001-10-16
ATE228850T1 (de) 2002-12-15
NZ508874A (en) 2004-03-26
CA2335340A1 (en) 2000-02-03
DE69928296T2 (de) 2006-07-27
DE69904262D1 (de) 2003-01-16
WO2000004913A1 (en) 2000-02-03
EP0974359A2 (en) 2000-01-26
AU776823B2 (en) 2004-09-23
ATE308990T1 (de) 2005-11-15
DK0974359T3 (da) 2003-03-03
AR020618A1 (es) 2002-05-22

Similar Documents

Publication Publication Date Title
NO20010326L (no) FSH og FSH-variantformuleringer, produkter og fremgangsmÕter
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
NO983635L (no) Dentalforbindelser, sammensetninger og produkter
NO20021449D0 (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
DK0965578T3 (da) Hidtil ukendt triglycerik og præparat, som omfatter dette
NO951447D0 (no) Organoaluminoksyprodukt, fremstilling og anvendelse
NO20030800D0 (no) Aminoalkylbenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte forderes fremstilling og preparater inneholdende de samme
NO20013237L (no) 3,3-biarylpiperidin og 2,2-biarylmorfolinderivater
IS5827A (is) Múskarín gerandefni og mótlyf
NO20021001D0 (no) Radiofarmasöytiske produkter og fremstilling derav
DK0910369T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder
NO983802D0 (no) Benzothiofener, formuleringer inneholdende samme og fremgangsmÕter
DK1025100T3 (da) 3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf
DK0811593T3 (da) 1,4-diaryl-2-flour-2-buten som insektcider og acaricider
HUP0102226A3 (en) Hyperforin derivatives, the use thereof and formulations containing them
NO20003268L (no) Hyperhydrert kitikolin, fremgangsmÕte og anvendelse
DE50107204D1 (de) 8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate
DK1102543T3 (da) Cariesbekæmpende mælkeprodukt og anvendelse deraf
NO953579D0 (no) Konsentrert vevskultur-produsert levende T. Gondii Bradyzoite og produkter derav
DK1192163T3 (da) Dithiepino[6,5-b]pyriner, beslægtede præparater og fremgangsmåder
NO20012327L (no) Metoder for omdannelse av interferonisoformer og produkter derav
IT1292534B1 (it) Procedimento per preparare e confezionare wuerstel.
DK1127052T3 (da) Substituerede 2-phenylbenzimidazoler, fremstilling og anvendelse heraf
NO981089D0 (no) Epoksy-azetidinoner, fremstilling og anvendelse derav
DE29604259U1 (de) Schmiedevorrichtung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application